Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jul;51(7):490-495.
doi: 10.1111/cup.14612. Epub 2024 Mar 28.

Multiple primary dermatofibrosarcoma protuberans tumors in a single patient with chromosomal microarray analysis: A case report and review

Affiliations
Free article
Review

Multiple primary dermatofibrosarcoma protuberans tumors in a single patient with chromosomal microarray analysis: A case report and review

Joseph S Durgin et al. J Cutan Pathol. 2024 Jul.
Free article

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a cutaneous sarcoma with a high propensity for local invasion and recurrence. Although it is a rare event, the occurrence of multiple tumors in a single patient raises a diagnostic dilemma, as metastatic disease should be differentiated from multiple primary malignant events. In more than 90% of DFSP, a pathogenic t(17;22) translocation leads to the expression of COL1A1::PDGFB fusion transcripts. Karyotype analysis, fluorescence in situ hybridization, and RT-PCR can be useful ancillary studies in detecting this characteristic rearrangement, and sequencing of the fusion transcript can be used to support a clonal origin in metastatic and multifocal disease. However, previous reports have demonstrated variable sensitivity of these assays, in part due to the high sequence variability of the COL1A1::PDGFB fusion. Here, we report a patient who developed two distinct DFSP tumors over the course of 7 years. Chromosomal microarray analysis identified distinctive genomic alterations in the two tumors, supporting the occurrence of multiple primary malignant events.

Keywords: array‐based CGH; dermatofibrosarcoma protuberans; multiple primary.

PubMed Disclaimer

References

REFERENCES

    1. Thway K, Noujaim J, Jones RL, Fisher C. Dermatofibrosarcoma protuberans: pathology, genetics and potential therapeutic strategies. Ann Diagn Pathol. 2016;25:64‐71. doi:10.1016/j.anndiagpath.2016.09.013
    1. Llombart B, Serra‐Guillén C, Monteagudo C, López Guerrero JA, Sanmartín O. Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management. Semin Diagn Pathol. 2013;30(1):13‐28. doi:10.1053/j.semdp.2012.01.002
    1. Hao X, Billings SD, Wu F, et al. Dermatofibrosarcoma protuberans: update on the diagnosis and treatment. J Clin Med. 2020;9(6):1752. doi:10.3390/jcm9061752
    1. Millare GG, Guha‐Thakurta N, Sturgis EM, El‐Naggar AK, Debnam JM. Imaging findings of head and neck dermatofibrosarcoma protuberans. Am J Neuroradiol. 2014;35(2):373‐378. doi:10.3174/ajnr.A3650
    1. Farma JM, Ammori JB, Zager JS, et al. Dermatofibrosarcoma protuberans: how wide should we resect? Ann Surg Oncol. 2010;17(8):2112‐2118. doi:10.1245/s10434‐010‐1046‐8

MeSH terms

Substances